| Literature DB >> 22018437 |
Fa-yu Liu1, Zhong-fei Xu, Peng Li, Chang-fu Sun, Rui-wu Li, Shu-fen Ge, Jun-lin Li, Shao-hui Huang, Xuexin Tan.
Abstract
BACKGROUND: The large defects resulting from head and neck tumour surgeries present a reconstructive challenge to surgeons. Although numerous methods can be used, they all have their own limitations. In this paper, we present our experience with cervicofacial and cervicothoracic rotation flaps to help expand the awareness and application of this useful system of flaps.Entities:
Mesh:
Year: 2011 PMID: 22018437 PMCID: PMC3235176 DOI: 10.1186/1477-7819-9-135
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Figure 1The surgical technique of the cervicofacial flap. A. The outline for the resection of the tumour and cervicofacial flap design. B. The defect following resection of the tumour. C. The flap was raised, and the neck dissection was completed. D. The donor site was closed primarily.
Twenty-one consecutive patients undergoing resection and reconstruction with cervicofacial or cervicothoracic flap.
| patient | sex | Age(y) | Defect Location | Pathologic diagnosis | Comorbid disease | Size (cm) | Neck dissection | Flap used | Associated flap | length of postoperative hospitalization(d) | complication | Acceptable appearance | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skin | Mucosa | ||||||||||||
| 1 | F | 59 | face | BCC | 3 × 3 | - | Cervicofacial | - | 11 | - | Yes | ||
| 2 | M | 74 | parotid | AC | Hy | 3 × 2 | SND | Cervicothoracic | - | 10 | - | Yes | |
| 3 | M | 78 | cheek | SCC | 6 × 4 | 4 × 3 | MRND | Cervicothoracic | PMMF | 12 | - | Yes | |
| 4 | F | 87 | parotid | MC | Hy + Dm | 5 × 4 | - | Cervicofacial | - | 10 | - | Yes | |
| 5 | M | 46 | face | FSa | 1.5 × 1.5 | - | Cervicofacial | - | 7 | - | Yes | ||
| 6 | M | 56 | cheek | SCC | 5 × 5 | 3.5 × 3 | RND | Cervicothoracic | PMMF | 10 | - | Yes | |
| 7 | F | 56 | parotid | SCC | Dm | 5 × 3 | MRND | Cervicothoracic | - | 9 | - | Yes | |
| 8 | M | 74 | parotid | AC | Cd | 6 × 5 | - | Cervicothoracic | - | 8 | - | Yes | |
| 9 | M | 50 | face | FSa | 3 × 3 | - | Cervicofacial | - | 9 | - | Yes | ||
| 10 | F | 65 | fossa orbitalis | SCC | Hy | 6 × 4 | - | Cervicofacial | TMF | 7 | - | Yes | |
| 11 | F | 68 | cheek | SCC | Hy + Dm | 4 × 4 | SND | Cervicofacial | - | 8 | - | Yes | |
| 12 | M | 53 | submaxillary region | ACC | 2 × 2 | SND | Cervicofacial | - | 12 | - | Yes | ||
| 13 | F | 68 | cheek | SCC | Hy | 6 × 5 | 2 × 1.5 | RND | Cervicothoracic | PMMF | 20 | epidermolysis | No |
| 14 | M | 48 | face | SCC | Dm | 6 × 6 | - | Cervicothoracic | - | 23 | necrosis of the distal tip | Yes | |
| 15 | F | 51 | Cheek | Am | 16 × 7 | - | Cervicothoracic | PMF | 8 | - | Yes | ||
| 16 | F | 64 | cheek | SCC | Dm + Hy | 4 × 4 | 2 × 2 | SND | Cervicothoracic | PMMF | 15 | epidermolysis | Yes |
| 17 | M | 78 | neck | SCC | Hy | 7 × 5 | RND | Cervicofacial | - | 7 | epidermolysis | Yes | |
| 18 | F | 77 | cheek | SCC | Hy | 3 × 3 | SND | Cervicothoracic | - | 10 | - | Yes | |
| 19 | M | 78 | Submental region | BCC | Hy | 5 × 3 | SND | Cervicothoracic | - | 8 | necrosis of the distal tip | Yes | |
| 20 | M | 53 | parotid | MC | 7 × 6 | RND | Cervicofacial | - | 8 | - | Yes | ||
| 21 | M | 72 | fossa orbitalis | BCC | 5 × 4 | - | Cervicofacial | TMF | 7 | - | Yes | ||
ACC: adenoid cystic carcinoma. SCC: squamous cell carcinoma. BCC: basal cell carcinoma. MC: myoepithelial carcinoma. FSa: fibrosarcoma. AC: adenocarcinoma Mc: mucoepidermoid carcinoma. Am: ameloblastoma.
Hy: Hypertension. Dm: diabetes mellitus. Cd: cardiac disease.
TMF: temporalis myofacial flap. PMF: pectoralis myofascial flap. PMMF: pectoralis major myocutaneous flap
Figure 2The combination of cervicothoracic rotation flaps and PMMF. A. The outline of the resection of the tumour and the design of the combination of cervicothoracic flaps and PMMF. B. The cervicothoracic flap and PMMF were raised after tumour resection. C. PMMF was used to reconstruct the mucosa, and the cervicothoracic flap was used to cover the defect. The donor site was closed primarily.
Figure 3The combination of cervicofacial rotation flap and TMF. A. The design of the TMF and cervicofacial flap after the tumour was resected. B. The TMF was rotated and advanced to replenish the orbital defect, and the cervicofacial flap was raised. C. The orbital defect was closed with no significant contour deformity. D. Result 2 months postoperatively.